Loading...
A256940 logo

Keeps Biopharma Inc.KOSDAQ:A256940 Stock Report

Market Cap ₩210.8b
Share Price
₩10.50k
n/a
1Y120.6%
7D13.8%
Portfolio Value
​
View

Keeps Biopharma Inc.

KOSDAQ:A256940 Stock Report

Market Cap: ₩210.8b

Keeps Biopharma (A256940) Stock Overview

Engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. More details

A256940 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Risk Analysis

Volatile share price over the past 3 months compared to the KR market


A256940 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Keeps Biopharma Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Keeps Biopharma
Historical stock prices
Current Share Price₩10,500.00
52 Week High₩22,150.00
52 Week Low₩4,160.00
Beta1.6
1 Month Change19.05%
3 Month Change-23.19%
1 Year Change120.59%
3 Year Change43.64%
5 Year Change-48.28%
Change since IPO77.46%

Recent News & Updates

Keeps Biopharma Inc.'s (KOSDAQ:256940) Shares Not Telling The Full Story

Dec 01
Keeps Biopharma Inc.'s (KOSDAQ:256940) Shares Not Telling The Full Story

Is Keeps Biopharma (KOSDAQ:256940) Using Too Much Debt?

Sep 06
Is Keeps Biopharma (KOSDAQ:256940) Using Too Much Debt?

Not Many Are Piling Into Keeps Biopharma Inc. (KOSDAQ:256940) Stock Yet As It Plummets 27%

Aug 01
Not Many Are Piling Into Keeps Biopharma Inc. (KOSDAQ:256940) Stock Yet As It Plummets 27%

Market Participants Recognise Keeps Biopharma Inc.'s (KOSDAQ:256940) Revenues Pushing Shares 43% Higher

Jun 17
Market Participants Recognise Keeps Biopharma Inc.'s (KOSDAQ:256940) Revenues Pushing Shares 43% Higher

Recent updates

Keeps Biopharma Inc.'s (KOSDAQ:256940) Shares Not Telling The Full Story

Dec 01
Keeps Biopharma Inc.'s (KOSDAQ:256940) Shares Not Telling The Full Story

Is Keeps Biopharma (KOSDAQ:256940) Using Too Much Debt?

Sep 06
Is Keeps Biopharma (KOSDAQ:256940) Using Too Much Debt?

Not Many Are Piling Into Keeps Biopharma Inc. (KOSDAQ:256940) Stock Yet As It Plummets 27%

Aug 01
Not Many Are Piling Into Keeps Biopharma Inc. (KOSDAQ:256940) Stock Yet As It Plummets 27%

Market Participants Recognise Keeps Biopharma Inc.'s (KOSDAQ:256940) Revenues Pushing Shares 43% Higher

Jun 17
Market Participants Recognise Keeps Biopharma Inc.'s (KOSDAQ:256940) Revenues Pushing Shares 43% Higher

Is Keeps Biopharma (KOSDAQ:256940) A Risky Investment?

May 15
Is Keeps Biopharma (KOSDAQ:256940) A Risky Investment?

Further Upside For Keeps Biopharma Inc. (KOSDAQ:256940) Shares Could Introduce Price Risks After 33% Bounce

Apr 18
Further Upside For Keeps Biopharma Inc. (KOSDAQ:256940) Shares Could Introduce Price Risks After 33% Bounce

A Piece Of The Puzzle Missing From KPS Corporation's (KOSDAQ:256940) 33% Share Price Climb

Feb 06
A Piece Of The Puzzle Missing From KPS Corporation's (KOSDAQ:256940) 33% Share Price Climb

KPS (KOSDAQ:256940) Takes On Some Risk With Its Use Of Debt

Jan 13
KPS (KOSDAQ:256940) Takes On Some Risk With Its Use Of Debt

A Piece Of The Puzzle Missing From KPS Corporation's (KOSDAQ:256940) Share Price

Dec 06
A Piece Of The Puzzle Missing From KPS Corporation's (KOSDAQ:256940) Share Price

KPS (KOSDAQ:256940) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Mar 31
KPS (KOSDAQ:256940) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Sentiment Still Eluding KPS Corporation (KOSDAQ:256940)

Feb 26
Sentiment Still Eluding KPS Corporation (KOSDAQ:256940)

Shareholder Returns

A256940KR SemiconductorKR Market
7D13.8%7.3%4.2%
1Y120.6%183.4%57.2%

Return vs Industry: A256940 underperformed the KR Semiconductor industry which returned 183.4% over the past year.

Return vs Market: A256940 exceeded the KR Market which returned 57.2% over the past year.

Price Volatility

Is A256940's price volatile compared to industry and market?
A256940 volatility
A256940 Average Weekly Movement11.2%
Semiconductor Industry Average Movement7.9%
Market Average Movement5.3%
10% most volatile stocks in KR Market11.3%
10% least volatile stocks in KR Market2.6%

Stable Share Price: A256940's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A256940's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2000109Young Kim Hawww.kpscorp.co.kr

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing.

Keeps Biopharma Inc. Fundamentals Summary

How do Keeps Biopharma's earnings and revenue compare to its market cap?
A256940 fundamental statistics
Market cap₩210.82b
Earnings (TTM)-₩28.35m
Revenue (TTM)₩157.75b
1.3x
P/S Ratio
-7,437x
P/E Ratio

Is A256940 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A256940 income statement (TTM)
Revenue₩157.75b
Cost of Revenue₩128.98b
Gross Profit₩28.77b
Other Expenses₩28.80b
Earnings-₩28.35m

Last Reported Earnings

Sep 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-1.41
Gross Margin18.24%
Net Profit Margin-0.018%
Debt/Equity Ratio78.8%

How did A256940 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/03 00:44
End of Day Share Price 2025/12/03 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Keeps Biopharma Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
YoungSik YoonShinhan Investment Corp.
Sun-Jae HeoSK Securities Co., Ltd.